Covered recipient · General Payments record
SAMEERA RASHEED
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2023–2024
$665.72
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $566.72 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $183.45 | 9 |
| Alkermes, Inc. | $167.66 | 7 |
| Indivior Inc. | $55.86 | 2 |
| Almatica Pharma Inc. | $48.15 | 2 |
| Supernus Pharmaceuticals, Inc. | $40.67 | 2 |
| Janssen Pharmaceuticals, Inc | $20.79 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.53 | 1 |
| Noven Therapeutics, LLC | $16.34 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.93 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381044 | CMS |
| ABBVIE INC. | $28.41 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381048 | CMS |
| ABBVIE INC. | $20.68 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381053 | CMS |
| ABBVIE INC. | $18.78 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381057 | CMS |
| ABBVIE INC. | $23.23 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381061 | CMS |
| ABBVIE INC. | $18.62 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381065 | CMS |
| ABBVIE INC. | $3.58 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381069 | CMS |
| ABBVIE INC. | $24.43 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381073 | CMS |
| ABBVIE INC. | $19.79 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381077 | CMS |
| Alkermes, Inc. | $23.32 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578751 | CMS |
| Alkermes, Inc. | $22.08 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578753 | CMS |
| Alkermes, Inc. | $16.92 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578755 | CMS |
| Alkermes, Inc. | $18.06 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578757 | CMS |
| Alkermes, Inc. | $22.94 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578759 | CMS |
| Alkermes, Inc. | $34.58 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578761 | CMS |
| Alkermes, Inc. | $29.76 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120578763 | CMS |
| Almatica Pharma LLC | $28.60 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137576067 | CMS |
| Almatica Pharma LLC | $19.55 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137576071 | CMS |
| Indivior Inc. | $30.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144536157 | CMS |
| Indivior Inc. | $24.89 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144536159 | CMS |
| Janssen Pharmaceuticals, Inc | $20.79 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078201151 | CMS |
| Noven Therapeutics, LLC | $16.34 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084825279 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.53 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118966953 | CMS |
| Supernus Pharmaceuticals, Inc. | $19.23 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147823446 | CMS |
| Supernus Pharmaceuticals, Inc. | $21.44 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147823448 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.27 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151580397 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.